To examine the effect of SB-505124 and TGF-β1 co-treatment on Lewis lung carcinoma (LLC) cells, we first noted that TGF-β1 treatment alone reduced the expression of the junctional E-cadherin protein by 94% in the LLC cells. The gene discussed is TGFB1; the disease is Carcinoma, Lewis Lung.